Trial intelligence / Profile preview

Comparison of Pasteur Institute of Iran and Heber Biotec hepatitis B vaccines in healthy Iranian volunteers

IRCT201109113307N5Phase 2Completed

Sponsor
Institut Pasteur
Start
Sep 2011
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by Institut Pasteur. Started Sep 2011; status: completed.

02

Drugs

Hepatitis B vaccine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on IRCT201109113307N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201109113307N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call